Company Profile
Cue Health Stock Price, News & Analysis
- Ticker:
- HLTH
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
26.23 USD (-1.75%)
Close
Last updated: August 6, 2026
—
Market cap
Why the stock is moving
As of Aug 6, 2026, HLTH closed down 1.75% at $26.23. No new same-company headline was identified in the current news window.
Company overview
Business overview
Cue Health was a diagnostics company focused on portable testing and connected health before its restructuring and business decline. Its platform aimed at point-of-care diagnostics for consumers and healthcare settings.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ before restructuring, Cue Health sat in diagnostics and medical devices.
Business Model Characteristics
The business depended on test adoption, product execution, and scaling point-of-care diagnostics.
Position Within the Biotechnology Landscape
Cue Health belongs to the historical diagnostics and restructuring category rather than the current live public-company set.
Future catalysts
Cue Health is now a legacy / restructuring story, so the catalysts are any final strategic or asset-closure update rather than product growth. The company is no longer a live diagnostic growth story.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Cue Health (HLTH)?
Cue Health (HLTH) most recently closed at 26.23 USD, a -1.75% move versus the previous session.
What does Cue Health do?
Cue Health was a diagnostics company focused on portable testing and connected health before its restructuring and business decline. Its platform aimed at point-of-care diagnostics for consumers and healthcare settings.
On which exchange is HLTH stock listed?
Cue Health (HLTH) is associated with NASDAQ, United States, MedTech.
What is Health?
Cue Health is now a legacy / restructuring story, so the catalysts are any final strategic or asset-closure update rather than product growth.
Which conditions is Cue Health targeting with Health?
Cue Health is now a legacy / restructuring story, so the catalysts are any final strategic or asset-closure update rather than product growth.
How does Cue Health describe recent progress with Health?
Cue Health is now a legacy / restructuring story, so the catalysts are any final strategic or asset-closure update rather than product growth.
What future catalysts are investors watching for Cue Health?
Cue Health is now a legacy / restructuring story, so the catalysts are any final strategic or asset-closure update rather than product growth. The company is no longer a live diagnostic growth story.